What is Boston Scientific's revenue?

Boston Scientific (BSX) generated $20.6B in revenue over the trailing twelve months, up 17.4% year over year.

Is Boston Scientific profitable?

Boston Scientific reported $3.6B in net income over the trailing twelve months, a 17.3% net margin.

What are Boston Scientific's profit margins?

Gross margin is 69.2% and operating margin is 18.4%, with a 17.3% net margin.

What is Boston Scientific's earnings per share?

Boston Scientific's diluted EPS over the trailing twelve months is $2.39.

Where does Boston Scientific's income statement data come from?

Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Boston Scientific BSX Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$20.62B+2.7%	$20.08B+3.7%	$19.35B+4.6%	$18.49B+5.4%	$17.55B+4.8%
Total cost of revenue	$6.36B+2.2%	$6.22B+2.3%	$6.08B+3.6%	$5.87B+6.7%	$5.5B+4.6%
Gross profit	$14.26B+2.9%	$13.85B+4.4%	$13.27B+5.1%	$12.63B+4.8%	$12.05B+4.9%
Gross margin	69.2%+0.1pp	69%+0.4pp	68.6%+0.3pp	68.3%-0.4pp	68.7%+0.1pp
Selling, general and administrative	$7.07B+2.7%	$6.89B+3.3%	$6.67B+2.8%	$6.49B+4.3%	$6.22B+3.9%
Total operating expenses	$10.47B+2.2%	$10.24B+4.4%	$9.81B+3.5%	$9.48B+3.0%	$9.2B+3.5%
Operating income	$3.79B+5.0%	$3.61B+4.3%	$3.46B+10.0%	$3.15B+10.5%	$2.85B+9.5%
Operating margin	18.4%+0.4pp	18%+0.1pp	17.9%+0.9pp	17%+0.8pp	16.2%+0.7pp
Interest expense	$357M+2.3%	$349M+2.9%	$339M+2.4%	$331M+4.1%	$318M+4.3%
Income before income taxes	$3.74B+10.5%	$3.39B+3.5%	$3.27B+9.0%	$3B+21.0%	$2.48B+8.6%
Income tax expense	$183M-62.8%	$492M+1.4%	$485M-3.4%	$502M+10.6%	$454M+4.1%
Net income	$3.56B+23.1%	$2.89B+3.9%	$2.78B+11.5%	$2.5B+23.4%	$2.02B+9.7%
Net margin	17.3%+2.9pp	14.4%0.0pp	14.4%+0.9pp	13.5%+2.0pp	11.5%+0.5pp
Diluted earnings per share	$2.39+23.2%	$1.94+3.7%	$1.87+11.3%	$1.68+22.6%	$1.37+9.6%
EBITDA	$5.19B+4.1%	$4.98B+3.5%	$4.81B+7.9%	$4.46B+7.8%	$4.14B+6.9%
EBITDA margin	25.2%+0.3pp	24.8%-0.1pp	24.9%+0.7pp	24.1%+0.6pp	23.6%+0.5pp
EBIT	$3.79B+5.0%	$3.61B+4.3%	$3.46B+10.0%	$3.15B+10.5%	$2.85B+9.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Boston Scientific.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Boston Scientific's revenue?: Boston Scientific (BSX) generated $20.6B in revenue over the trailing twelve months, up 17.4% year over year.
Is Boston Scientific profitable?: Boston Scientific reported $3.6B in net income over the trailing twelve months, a 17.3% net margin.
What are Boston Scientific's profit margins?: Gross margin is 69.2% and operating margin is 18.4%, with a 17.3% net margin.
What is Boston Scientific's earnings per share?: Boston Scientific's diluted EPS over the trailing twelve months is $2.39.
Where does Boston Scientific's income statement data come from?: Every line is extracted from Boston Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.